Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Oncol-2015'

Oncol-2015 published presentations and documents on DocSlides.

ARRO Case Low Grade
ARRO Case Low Grade
by anderson
Glioma (LGG) Stephanie Rice, BS (MSIV), Abigail T....
Management of gastric cancer
Management of gastric cancer
by elizabeth
THEME Reprinted from Australian Family Physician ...
Colorectal cancer in young
Colorectal cancer in young
by olivia
adults: The focus on hereditary cancer syndromes ...
Page 2 of 33Liand Song J Hematol Oncol 2021 1456
Page 2 of 33Liand Song J Hematol Oncol 2021 1456
by adia
normal stem/progenitor cells in the bone marrow an...
wwwajmccomMAY
wwwajmccomMAY
by isabella
 CLINICAL The nalysis of SBRT Versus IR...
Cell Lung Cancer
Cell Lung Cancer
by eloise
Non - small Locally Advanced Daniel W. Golden MD,...
0J0H0Z0L030Y0L0W0V0Y0
0J0H0Z0L030Y0L0W0V0Y0
by lucy
Hematol Oncol Stem Cell Ther 1(2) April 2008 h...
British Gynaecological Cancer Society BGCS Cer
British Gynaecological Cancer Society BGCS Cer
by byrne
1 vical Cancer Guidelines: Recommendations for Pr...
Crit Rev Oncol Hematol2000333169185Shinke T Shite J Takaoka H
Crit Rev Oncol Hematol2000333169185Shinke T Shite J Takaoka H
by joy
.
Beth Sandy, MSN, CRNP Nurse Practitioner
Beth Sandy, MSN, CRNP Nurse Practitioner
by PriceOfFreedom
Abramson Cancer Center . University of Pennsylvani...
ML for personalised
ML for personalised
by CuteKitten
radiotherapy. Dr. Alex Zwanenburg. 06.12.2021. Why...
Peritoneal Nodules and Cytoreductive
Peritoneal Nodules and Cytoreductive
by Dragonfruit
Surgery. By . dr.Ahmed. . Samir. Surgical oncolog...
Birgitte V. Offersen Dept. of
Birgitte V. Offersen Dept. of
by TacoBellDiego
Experimental Clinical Oncology, . Aarhus Universit...
Tanya M. Wildes, MD, MSCI
Tanya M. Wildes, MD, MSCI
by HoneyBun
June 28, 2018. Management of hematologic malignanc...
GI cancers: targeted treatments
GI cancers: targeted treatments
by finley
and IO approaches for advanced/metastatic disease....
Treatment-related Adverse Effects in MDS:
Treatment-related Adverse Effects in MDS:
by emmy
Managing Them Before They Derail Therapy. Amy E. D...
iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung
iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung
by berey
Interview with Shirish M . Gadgeel. , MD . January...
Decision Making in Pediatric Palliative Care
Decision Making in Pediatric Palliative Care
by heavin
Scott Maurer, MD. Assistant Professor of Pediatric...
Fulvestrant 500 mg versus
Fulvestrant 500 mg versus
by elena
anastrozole. as first-line treatment for advanced...
Case Study: A P atient
Case Study: A P atient
by faith
with PV and . Debilitating . S. ymptoms on HU. Srd...
Mechanisms of ALK Resistance & Implications for Treatment
Mechanisms of ALK Resistance & Implications for Treatment
by evans
Robert C. Doebele, MD, PhD. Associate Professor, ....
Thomas E. Keane Medical University of South Carolina
Thomas E. Keane Medical University of South Carolina
by valerie
Charleston, SC. Bones, Hot Flashes, and ADT Use Wi...
Understanding Risk Factors of Cardiovascular Disease and Management Guidance for Men on Androgen De
Understanding Risk Factors of Cardiovascular Disease and Management Guidance for Men on Androgen De
by jacey
Prostate Cancer . US Medical Affairs, Research . a...
Screening, Geriatric Assessment and Interventions
Screening, Geriatric Assessment and Interventions
by layla
Pierre . Soubeyran. and Siri Rostoft. Disclosure....
Immuno-Oncology Adverse Event Management
Immuno-Oncology Adverse Event Management
by everly
Why is it different? . Why is it important?. Dr Av...
Anticoagulant Options for the Management of Acute Cancer-Associated Thrombosis
Anticoagulant Options for the Management of Acute Cancer-Associated Thrombosis
by collectmcdonalds
Presented by. Faculty/Presenter Disclosure. Facult...
by warlikebikers
cancer. , right vs . left. : . how. to take . it....
DRA. CRUZ MORALES GEORGINA R1GO
DRA. CRUZ MORALES GEORGINA R1GO
by bubbleba
TUMORES DEL ESTROMA GONADAL. Temario. Introducció...
Patient Selection for PARP
Patient Selection for PARP
by sherrill-nordquist
Inhibitors:. Purpose and Practicalities . Present...
The Role of Antiangiogenic Agents
The Role of Antiangiogenic Agents
by luanne-stotts
The Role of Antiangiogenic Agents in the Changin...
Michael A. Postow, MD
Michael A. Postow, MD
by kittie-lecroy
Michael A. Postow, MD Assistant Attending Physici...
CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data
CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data
by min-jolicoeur
CDK 4/6 Inhibitors in Breast Cance...
It takes more than milk to improve bone health!!
It takes more than milk to improve bone health!!
by aaron
Lawrence Drudge-Coates. Urological Oncology Clini...
ADVANCES IN THERAPY FOR SARCOMA AND GIST
ADVANCES IN THERAPY FOR SARCOMA AND GIST
by ellena-manuel
Angela . Cioffi. , MD. Sarcoma Research Program c...
Managing Advanced Renal Cell
Managing Advanced Renal Cell
by debby-jeon
Carcinoma: Balancing . Efficacy with Quality of L...
IMMUNOTHERAPY Group 6 Melinda Bachini, Thelma Brown, Jean Di Carlo-Wagner, Bob Riter, Chris Kinsing
IMMUNOTHERAPY Group 6 Melinda Bachini, Thelma Brown, Jean Di Carlo-Wagner, Bob Riter, Chris Kinsing
by conchita-marotz
IMMUNOTHERAPY. Preventative. Vaccines. HPV. Hepa...
19 th Annual NOCR Meeting
19 th Annual NOCR Meeting
by cheryl-pisano
Session I: Breast Cancer. Bone Directed Therapy ...
Cancer Unknown Primary Sarah W. Gordon, DO
Cancer Unknown Primary Sarah W. Gordon, DO
by olivia-moreira
Assistant Professor. Virginia Commonwealth Univer...
Sipuleucel -T Survival Benefit
Sipuleucel -T Survival Benefit
by calandra-battersby
Sipuleucel. -T was approved based on HR of 0.775 ...
Alexander Olinger , PharmD
Alexander Olinger , PharmD
by mitsue-stanley
PGY-2 Oncology Pharmacy Resident. Pharmacy Grand...